[1] Kalaitzakis E,Olsson R,Henfridsson P,et al.Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis.Liver Int,2007,27(9):1194-1201. [2] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南(2015年版).实用肝脏病杂志,2016,19(3):Ⅴ-ⅩⅩⅢ. [3] 中华医学会肝病学分会和感染病学分会. 《丙型肝炎防治指南》2015年更新版. 实用肝脏病杂志,2016,19(4):ⅠⅩ-ⅩⅩⅤⅠ. [4] 信丰智,范建高. 欧洲非酒精性脂肪性肝病诊疗指南简介. 实用肝脏病杂志,2016,19(4):ⅤⅡ-ⅤⅢ. [5] 中华医学会肝病学分会脂肪肝和酒精性肝病学组. 酒精性肝病诊疗指南. 中国肝脏病杂志(电子版),2010,2(4):49-53. [6] 王倩怡,贾继东. 自身免疫性肝病诊断与治疗进展. 传染病信息,2011,24(5):257-260. [7] Younossi ZM,Kiwi ML,Boparai N,et al.Cholestatic liver diseases and health-related quality of life.Am J Gastroenterol,2000,95(2):497-502. [8] Kalaitzakis E,Simrén M,Olsson R,et al.Gastrointestinal symptoms in patients with liver cirrhosis:associations with nutritional status and health-related quality of life. Scand J Gastroenterol,2006,41(12):1464-1472. [9] Zuberi BF,Memon AR,Afsar S,et al.Correlation of quality of life in patients of cirrhosis of liver with etiology and disease severity using disease-specific quality of life questionnaire. J Ayub Med Coll Abbottabad,2007,19(2):7-11. [10] Wunsch E,Naprawa G,Koziarska D,et al.Serum natremia affects health-related quality of life in patients with liver cirrhosis:a prospective,single centre study. Ann Hepatol,2013,12(3):448-455. [11] Doycheva I,Watt KD,Rifai G,et al.Increasing burden of chronic liver disease among adolescents and young adults in the USA:a silent epidemic. Dig Dis Sci,2017,62(5):1373-1380. [12] Torruellas C,French SW,Medici V.Diagnosis of alcoholic liver disease. World J Gastroenterol,2014,20(33):11684-11699. [13] Zein NN,Abdulkarim AS,Wiesner RH,et al.Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C,alcohol,or cholestatic disease. J Hepatol,2000,32(2):209-217. [14] Sigal SH,Stanca CM,Kontorinis N,et al.Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis.Am J Gastroenterol,2006,101(7):1490-1496. [15] Company L,Zapater P,Pérez-Mateo M,et al.Extrapyramidal signs predict the development of overt hepatic encephalopathy in patients with liver cirrhosis. Eur J Gastroenterol Hepatol,2010,22(5):519-525. [16] Svirtlih N,Pavic S,Terzic D,et al.Reduced quality of life in patients with chronic viral liver disease as assessed by SF12 questionnaire. J Gastrointestin Liver Dis,2008,17(4):405-409. [17] Gaglio P,Marfo K,Chiodo J.Hyponatremia in cirrhosis and end-stage liver disease:treatment with the vasopressin V(2)-receptor antagonist tolvaptan. Dig Dis Sci,2012,57(11):2774-2785. [18] Ennaifer R,Cheikh M,Romdhane H,et al.Hyponatremia in cirrhosis:risk factors and prognostic value. Tunis Med,2016,94(5):401-405. [19] Sigal SH.Hyponatremia in cirrhosis. J Hosp Med,2012,7(supplement 4):S14-17. [20] Guevara M,Baccaro ME,Torre A,et al.Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis:a prospective study with time-dependent analysis. Am J Gastroenterol,2009,104(6):1382-1389. [21] Tan HH,Lee GH,Thia KT,et al.Minimal hepatic encephalopathy runs a fluctuating course:results from a three-year prospective cohort follow-up study. Singapore Med J,2009,50(3):255-260. [22] Kudryavtseva M,Bezborodkina NN,Okovity SV,et al.Metabolic heterogeneity of glycogen in hepatocytes of patients with liver cirrhosis:the glycogen of the liver lobule zones in cirrhosis.Eur J Gastroenterol Hepatol,2001,13(6):693-697. [23] Vizzotto L,Vertemati M,Gambacorta M,et al.Analysis of histological and immunohistochemical patterns of the liver in posthepatitic and alcoholic cirrhosis by computerized morphometry. Mod Pathol,2002,15(8):798-806. [24] 张鸣,沈薇. 824例肝硬化病因及相关分析. 重庆医学,2006,25(5):438-439,441. [25] 梁晓峰,陈园生,王晓军,等. 中国3岁以上人群乙型肝炎血清流行病学研究. 中华流行病学杂志,2005,21(9):35-38. [26] 刘建萍,王亚婷,连玉萍. 输血后肝炎的感染调查及预防措施的探讨. 黑龙江医药,2009,22(2):213-215. [27] 刘炜炜,胡跃华,于石成,等. 中国大陆地区2008-2013年丙肝发病时空聚集性及社会经济影响因素. 中国公共卫生,2016,32(4):482-487. [28] 孔维宗,王迎春. 酒精性肝病的治疗进展. 现代医药卫生,2017,33(1):15-17. |